COMMUNIQUÉS West-GlobeNewswire

ReWalk Announces Preliminary Fiscal Year 2018 Revenue
14/01/2019
ReStore clinical study accrual and follow up completed YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., Jan. 14, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ ReWalk ” or the “ Company ”) today announced [...]
Nash Pharmaceuticals Announces Positive Pre-Clinical Results From a Second Study for Chronic Kidney Disease as well as 2 Additional Lead Targets
14/01/2019
New target Showed Synergy When Combined With Leading Drug Therapy VANCOUVER, British Columbia, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Nash Pharmaceuticals Inc., a wholly owned subsidiary of Breathtec Biomedical Inc. (CSE: [...]
Nabriva Therapeutics Provides Update on PDUFA Date for Intravenous CONTEPO™
14/01/2019
-PDUFA action date now set for April 30, 2019- DUBLIN, Ireland, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a clinical-stage biopharmaceutical company engaged in the research and [...]
Microbot Medical Increases its Global IP Portfolio with Notice of Allowance from the European Patent Office
14/01/2019
HINGHAM, Mass., Jan. 14, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ: MBOT), received a notification from the European Patent Office that it will grant a patent for Application No. 08738207, which covers the [...]
Aleafia Fulfills First Transaction Under Cannabis Supply Agreement with CannTrust
14/01/2019
Aleafia Cannabis Complements CannTrust’s Supply for growing Adult-use, Medical Sales TORONTO, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH) (“ Aleafia ” or the “ Company ”) [...]
Scilex Announces Addition of ZTlido® to Express Scripts National Formularies
14/01/2019
SAN DIEGO, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Scilex Pharmaceuticals Inc. (SCILEX), a subsidiary of Sorrento Therapeutics, Inc. (NASDAQ: SRNE), today announced that Express Scripts has added ZTlido ® (lidocaine topical [...]
Scilex Announces ZTlido® Insurance Coverage for ~100 Million Insured Lives(1)
14/01/2019
SAN DIEGO, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Scilex Pharmaceuticals Inc. (SCILEX), a subsidiary of Sorrento Therapeutics, Inc. (NASDAQ: SRNE), today announced that ZTlido ® (lidocaine topical system) 1.8% (ZTLIDO) is [...]
Ancient Nutrition Names Greg Shearson as CEO, Adding to Leadership Team of Founders Jordan Rubin and Dr. Josh Axe
14/01/2019
Former CEO of Merrick Natural Pet Care Brings 30 Years of Leadership Experience to Leading Natural Health and Wellness Brand NASHVILLE, Tenn., Jan. 14, 2019 (GLOBE NEWSWIRE) -- Ancient Nutrition announced today that [...]
Zomedica Announces $4.28 Million Private Placement Closing and Corporate Update
14/01/2019
ANN ARBOR, Mich., Jan. 14, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company, today announced the [...]
111, Inc. Presented at the 37th Annual J.P. Morgan Healthcare Conference
14/01/2019
SHANGHAI, China, Jan. 14, 2019 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced that it presented at the 37th Annual J.P. [...]
Digirad Names David Noble as Interim Chief Financial Officer
14/01/2019
SUWANEE, Ga., Jan. 14, 2019 (GLOBE NEWSWIRE) -- Digirad Corporation (Nasdaq: DRAD) (“Digirad”) today announced that David Noble, Digirad’s current Chief Operating Officer, will assume the additional role of Interim [...]
Arrayit Corporation Aces Fourth Consecutive Round of Proficiency Testing with a Top Proficiency Testing Company
14/01/2019
Sunnyvale, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, reports that its clinical team has aced four consecutive rounds of proficiency testing ( [...]
Nexstim Plc Depression Therapy Business Update
14/01/2019
Company announcement, Helsinki, 14 January 2019 at 09.00 Nexstim Plc Depression Therapy Business Update Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing pioneering [...]
Verona Pharma Reports Encouraging Top-Line Data from Three-Day Phase 2 Trial Evaluating Nebulized Ensifentrine (RPL554) on Top of Dual Bronchodilator Therapy for COPD Maintenance Treatment
14/01/2019
Results from this short clinical pharmacology trial inform and support further clinical development of ensifentrine as an add-on to dual and triple COPD therapy Investment community conference call scheduled for 8 am [...]
MDxHealth (R): MDxHealth Provides Business Update
14/01/2019
NEWS RELEASE REGULATED INFORMATION INSIDE INFORMATION January 14, 2019 - 07:00 CET Preliminary 2018 financial results Total genomic test volumes up 16% Implemented operational cost reduction of ~$10 Million IRVINE, CA, [...]
MDxHealth (R) : MDxHealth dévoile ses résultats de l'exercice 2018
14/01/2019
COMMUNIQUÉ DE PRESSE INFORMATIONS RÉGLEMENTÉES INFORMATIONS PRIVILEGIEES Le 14 janvier 2019 - 07h00 CET Résultat financier provisoire de l'exercice 2018 Augmentation du total des volumes de test génomique de 16 % Mise [...]
ASLAN Pharmaceuticals Announces Study Results from Phase 2 Study of Varlitinib in First-line Gastric Cancer
13/01/2019
SINGAPORE, Jan. 14, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ:ASLN, TPEx:6497), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in [...]
UPDATE - Immucor Announces Health Canada Approval for Echo Lumena™; Next Generation, Fully Automated Instrument Powers Smaller to Mid-Volume Labs
11/01/2019
Faster, clearer blood compatibility results now available NORCROSS, Ga., Jan. 11, 2019 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that its next [...]
Sanofi: Availability of the Pre-quarterly Results Communication
11/01/2019
Availability of the Pre-quarterly Results Communication Paris, France - January 11, 2019 - Sanofi announced today that its Pre-Quarterly Results Communication document is available on the "Investors" page of the company [...]

Pages